Clinical Trial Update: Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia

View source ↗

Summary

A completed pediatric AML biomarker study update from the Children's Oncology Group examining biomarkers in bone marrow from high-risk AML patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia Minimally Differentiated
• Acute Myeloid Leukemia with Maturation
• Basophilic Leukemia
• Eosinophilic Leukemia
• Erythroleukemia
• Megakaryoblastic Leukemia
• Monocytic Leukemia
• Myelomonocytic Leukemia

Snippet

Sponsor: Children's Oncology Group | Conditions: Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia | Status: COMPLETED